The Venture Codex Logo

The Venture Codex

Overview

Biopharmaceutical company developing targeted drugs for liver disease and c

Total Raised

$167 M

Rounds

2

Links

Verticals

Biotechnology
Health Care
Medical
Medical Device
Pharmaceutical

Investment History

  1. Series C

    Jan 2021

    $87M

  2. Series B

    Oct 2018

    $80M

Team

Amy Burroughs

Chief Executive Officer

Emil T. Kuriakose

Chief Medical Officer, Oncology

Melita Jung

Chief Business Officer

Jeff Jasper

Senior Vice President, Research